SCHEMBL122334

SCHEMBL122334

C1=CCCC2CCCCCC2=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL122551 0.98
SCHEMBL1052042 0.92 KDM1A (0.31)
SCHEMBL1052040 0.92 KDM1A (0.31)
SCHEMBL6015270 0.92 KDM1A (0.31)
SCHEMBL3982960 0.92 MAPT (0.31)
SCHEMBL481597 0.90 MAPT (0.30)
SCHEMBL1049799 0.90 MAPT (0.30)
SCHEMBL7638599 0.88
SCHEMBL7637193 0.88
SCHEMBL7637190 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 259 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1412393-A1 OLEFIN POLYMERIZATION CATALYSTS CONTAINING CHELATING DIANIONIC LIGANDS Equistar Chemicals, LP (US) 2004-04-28 EP claimed
US-6544918-B1 Efficiency EQUISTAR CHEMICALS, LP 2003-04-08 US claimed
US-20030055276-A1 OLEFIN POLYMERIZATION CATALYSTS CONTAINING CHELATING DIANIONIC LIGANDS EQUISTAR CHEMICALS, LP 2003-03-20 US claimed
WO-2003008464-A1 OLEFIN POLYMERIZATION CATALYSTS CONTAINING CHELATING DIANIONIC LIGANDS EQUISTAR CHEMICALS, LP (US) 2003-01-30 WO claimed
US-10117878-B2 Ligands for nematode nuclear receptors and uses thereof BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM (US) 2018-11-06 US disclosed
US-9856219-B2 Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors NIVALIS THERAPEUTICS, INC. (US) 2018-01-02 US disclosed
EP-3247715-A1 METHODS OF PREVENTING, REDUCING OR TREATING MACULAR DEGENERATION Inotek Pharmaceuticals Corporation (US) 2017-11-29 EP disclosed
US-9814700-B2 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents NIVALIS THERAPEUTICS, INC. (US) 2017-11-14 US disclosed
US-9707212-B2 S-nitrosoglutathione reductase inhibitors NIVALIS THERAPEUTICS, INC. (US) 2017-07-18 US disclosed
US-20170049750-A1 Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents LAUREL THERAPEUTICS LTD. (CN) 2017-02-23 US disclosed
US-20160367586-A1 COMBINATION, KIT AND METHOD OF REDUCING INTRAOCULAR PRESSURE INOTEK PHARMACEUTICALS CORPORATION 2016-12-22 US disclosed
EP-2555775-B1 COMBINATION COMPOSITIONS OF ADENOSINE A1 AGONISTS AND CARBONIC ANHYDRASE INHIBITORS FOR REDUCING INTRAOCULAR PRESSURE INOTEK PHARMACEUTICALS CORP (US) 2016-12-07 EP disclosed
WO-2005118538-A2 ARYLSULFONAMIDES AND USES AS HYDROXYSTEROID DEHYDROGENASE AMGEN, INC. (US) 2005-12-15 WO disclosed
WO-2005110980-A2 ARYL SULFONES AND USES RELATED THERETO AMGEN, INC. (US) 2005-11-24 WO disclosed
WO-2005063247-A1 ARYL SULFONAMIDE COMPOUNDS AND USES RELATED THERETO AMGEN INC. (US) 2005-07-14 WO disclosed
WO-2005051942-A1 INDAZOLE COMPOUNDS AND METHODS OF USE THEREOF AS PROTEIN KINASE INHIBITORS SIGNAL PHARMACEUTICALS, LLC (US) 2005-06-09 WO disclosed
EP-1412393-A1 OLEFIN POLYMERIZATION CATALYSTS CONTAINING CHELATING DIANIONIC LIGANDS Equistar Chemicals, LP (US) 2004-04-28 EP disclosed
US-6544918-B1 Efficiency EQUISTAR CHEMICALS, LP 2003-04-08 US disclosed
US-20030055276-A1 OLEFIN POLYMERIZATION CATALYSTS CONTAINING CHELATING DIANIONIC LIGANDS EQUISTAR CHEMICALS, LP 2003-03-20 US disclosed
WO-2003008464-A1 OLEFIN POLYMERIZATION CATALYSTS CONTAINING CHELATING DIANIONIC LIGANDS EQUISTAR CHEMICALS, LP (US) 2003-01-30 WO disclosed